Ignite Creation Date:
2024-05-05 @ 11:54 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00176527
Status:
TERMINATED
Last Update Posted:
2009-12-11
First Post:
2005-09-12
Brief Title:
Isotretinoin Interferon Alfa-2b Docetaxel and Estramustine in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy
Sponsor:
University of Medicine and Dentistry of New Jersey
Organization:
Rutgers The State University of New Jersey
Organization Data
Organization:
Rutgers The State University of New Jersey
Class:
OTHER
Study ID:
CDR0000540176
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Medicine and Dentistry of New Jersey
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Robert DiPaola MD
Old Organization:
UMDNJCINJ
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |